Navigation Links
Therapies to improve biochemical functions hold promise as treatments for autism
Date:6/2/2011

Two promising new treatments to aid people with autism have shown effectiveness in pilot studies conducted by an Arizona State University professor and private researchers.

Several studies indicate that children with autism often have abnormalities in critical biochemical functions that help maintain health specifically methylation, glutathione, and mitochondrial functions.

Methylation turns proteins in the body on and off including DNA and RNA a function that controls gene activity.

Glutathione, a primary antioxidant, provides a defense against toxic metals in the body. Mitochondria are essentially the "factories" inside body cells that produce energy.

The research team has been developing therapies aimed at restoring or improving these functions in people with autism experiencing abnormalities.

The complete study is published in the medical journal Autism Insights, and is available online at http://la-press.com/article.php?article_id=2665

The team includes:

  • James Adams, a professor in the School for Engineering of Matter, Transport and Energy, one of ASU's Ira A. Fulton Schools of Engineering
  • Stuart Freedenfeld, physician and medical director with Stockton Family Practice, in Stockton, N.J.
  • Tapan Audhya, a biochemist with the Health Diagnostics and Research Institute, in South Amboy, N.J.
  • Kim Hamada, a registered nurse with Stockton Family Practice.

A common feature of the abnormalities the researchers are studying is that they are affected directly or indirectly by levels of specific substances produced by the body ribose and nicotinamide adenine dinucleotide, or NADH.

Use of ribose and NADH supplements have been reported to boost levels of adenosine-5'-triphosphate, or ATP a primary fuel source for the body and the brain. The supplements have also been shown to be helpful in treating chronic fatigue.

The research team explored use of ribose and NADH supplements as treatments for autism in two parallel studies using ribose and NADH.

One study investigated the effect of supplementation with NADH, an important co-factor for many enzymatic reactions in the body.

Another study investigated the effect of supplementation with ribose, a special sugar made by the body from glucose.

The studies found use of ribose and NADH supplements had similar effects, boosting levels of methylation, glutathione and ATP after only two weeks of therapy.

Levels of ribose and NADH also improved substantially, without adverse effects. After just two weeks of therapy, one child in each group was reported to have some improvement in energy level.

The biochemistry of both NADH and ribose is well-established, as well as how both affect production of ATP, glutathione and methylation. Details are provided in the article in Autism Insights.

Adams points out that both treatments use products that are available as over-the-counter nutritional supplements.

Larger and more formal studies are needed to confirm the benefits of ribose and NADH supplements, Freedenfeld says.

But "these therapies appear to be safe and effective supportive therapies for restoring methylation, glutathione and ATP to near-normal levels in the body, and are likely to help children with autism who experience problems maintaining normal functions," he says.


'/>"/>

Contact: Joe Kullman
joe.kullman@asu.edu
480-965-8122
Arizona State University
Source:Eurekalert

Related biology news :

1. Landmark study unlocks stem cell, DNA secrets to speed therapies
2. Efavirenz-based initial therapies associated with better outcomes in HIV-infected adults
3. Mechanisms of cardiovascular disease and cancer give clues to new therapies
4. Pigs and dogs can bridge gap between mice and humans in developing new therapies
5. Digital communication technology helps clear path to personalized therapies
6. Cancer-causing gene discovery suggests new therapies
7. Common gene variants increase risk of hypertension, may lead to new therapies
8. ChemoBrain: How cancer therapies can affect your mind
9. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
10. Amniotic fluid may provide new source of stem cells for future therapies
11. Publication sets guidelines across cancer therapies: Ensuring the best in patient management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" or ... China , today announced that its board of ... date of the plan from March 27, 2017 to March 27, ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
(Date:3/24/2017)... LEXINGTON, Mass. , March 24, 2017 ... pipeline of immune checkpoint antibodies and cancer vaccines, today ... The 7 th  Annual William Blair and Maidstone ... Event Space Alexandria Center in New York, ... March 29 at 9:40 am: ...
(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today ... for the sale of 12,835,490 shares of its common ...  ecosystem of companies. In connection with the sale of its ... in cash and issue to GlobeImmune 200,000 shares, an ... "We are pleased to enter into ...
Breaking Biology Technology: